Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
03/2010
03/25/2010WO2010033444A1 Crystalline forms of a 2-thiazolyl- 4-quinolinyl-oxy derivative, a potent hcv inhibitor
03/25/2010WO2010033270A1 Dibenzothiazepine modulators of dopamine, alpha adrenergic, and serotonin receptors
03/25/2010WO2010032856A1 Nitrogen-containing heterocyclic compound and use of same
03/25/2010WO2010031713A1 Substituted pyrrolidine-2-carboxamides
03/25/2010WO2010031589A1 Small molecule bradykinin b2 receptor modulators
03/25/2010WO2010013078A3 Pyrrolidinyl-alkyl-amide derivatives their preparation and their therapeutic application as ccr3 receptor ligands
03/25/2010WO2009154741A8 Thiophene or thiazole derivatives and their use as pi3k inhibitors
03/25/2010US20100076188 2-((4,6-dimethoxy)pyrimidin-2-yl-),3-(methoxy-), 3,3-(diphenyl)propionic acid; antihypotensive agents; pulmonary hypertension, mycocardial necrosis; renal failure; brain disorders; antispasmodic agents; antiischemic agents; coagulants; asthma; atherosclerosis; restenosis; Raynaud's syndrome
03/25/2010US20100076051 Isoindolinone kinase inhibitors
03/25/2010US20100076014 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF
03/25/2010US20100075988 Tetrahydroquinazoline compounds and their use in preparing medicaments for treating and preventing virosis
03/25/2010US20100075971 Substituted pyridine derivatives useful in the treatment of cancer and other disorders
03/25/2010US20100075970 Inhibitors of akt activity
03/25/2010US20100075959 Benzothiazole derivatives with activity as adenosine receptor ligands
03/25/2010US20100075957 Aminodihydrothiazine derivatives substituted with a cyclic group
03/25/2010US20100075956 N-(1-arylpyrazol-4l)sulfonamides and their use as parasiticides
03/25/2010US20100075953 Substituted piperazines, (1,4) diazepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
03/25/2010US20100075951 Heteroaryls and uses thereof
03/25/2010US20100075931 Substituted oxazole ketone modulators of fatty acid amide hydrolase
03/25/2010CA2737199A1 Novel compounds as cannabinoid receptor ligands
03/25/2010CA2737055A1 Crystalline forms of a 2-thiazolyl- 4-quinolinyl-oxy derivative, a potent hcv inhibitor
03/25/2010CA2736955A1 Multiheteroaryl compounds as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases
03/25/2010CA2734363A1 Substituted pyrrolidine-2-carboxamides
03/24/2010EP2166003A1 Excitatory amino acid receptor antagonists
03/24/2010EP2164847A1 3-aza-bicyclo[3.3.0]octane compounds
03/24/2010EP2164846A2 Heteroaryl substituted thiazoles and their use as antiviral agents.
03/24/2010EP2164845A1 Novel 4-heteroaryl-imidazole-2-thiones used as tyrosinase inhibitors, method for preparing same and use thereof in human medicine and cosmetology
03/24/2010EP2164844A1 Pyrimidinyl pyridazinone derivates
03/24/2010EP2164843A1 Pyridazinone derivates
03/24/2010EP2164842A2 Thiazoles and pyrazoles useful as kinase inhibitors
03/24/2010EP2164326A1 Amide compounds and the use thereof
03/24/2010EP1644357B9 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
03/24/2010EP1615699B1 Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors
03/24/2010EP1389110B1 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
03/24/2010CN101679406A Thiazolyl compounds useful as kinase inhibitors
03/24/2010CN101679405A 2-aminopyridine analogs as glucokinase activators
03/24/2010CN101679404A piperidine-amide derivatives
03/24/2010CN101679388A Novel 4-heteroaryl-imidazole-2-thiones used as tyrosinase inhibitors, method for preparing same and use thereof in human medicine and cosmetology
03/24/2010CN101679387A Aminopyrimidines useful as kinase inhibitors
03/24/2010CN101679378A Thiazoles and pyrazoles useful as kinase inhibitors
03/24/2010CN101679377A Heterocyclic hydrazide compound and pesticidal use of the same
03/24/2010CN101679375A 8-oxy-quinoline derivatives as bradykinin b2 receptor modulators
03/24/2010CN101679371A Substituted pyrimidines as adenosine receptor antagonists
03/24/2010CN101679370A Novel vanilloid receptor ligands and the use thereof for the production of pharmaceuticals
03/24/2010CN101679366A pyridyl piperidine orexin receptor antagonists
03/24/2010CN101679361A Certain substituted amides, method of making, and method of use thereof
03/24/2010CN101679359A Quinolines and their therapeutic use
03/24/2010CN101679357A Substituted heterocyclic derivatives and their pharmaceutical use and compositions
03/24/2010CN101679355A benzimidazole cannabinoid agonists
03/24/2010CN101679354A Novel triazinedione derivatives as GABAB receptor modulators
03/24/2010CN101679351A Quinoline compounds suitable for treating didorders that respond to modulation of the serotonin 5-ht6 receptor
03/24/2010CN101679345A Novel microbiocides
03/24/2010CN101679327A Substituted phenoxy aminothiazolones as estrogen related receptor-alpha modulators
03/24/2010CN101679326A Substituted phenoxy n-alkylated thiazoledinedione as estrogen related receptor-alpha modulators
03/24/2010CN101679325A modulators of pharmacokinetic properties of therapeutics
03/24/2010CN101679318A Development of molecular imaging probes for carbonic anhydrase-IX using click chemistry
03/24/2010CN101679313A Axl kinase inhibitors used in cancer or excess proliferative disease
03/24/2010CN101679306A Heteroarylamide pyrimidone derivatives
03/24/2010CN101679303A pyridazinone derivatives
03/24/2010CN101679279A Sulfonylpyrazole and sulfonylpyrazoline carboxamidine derivatives as 5-ht6 antagonists
03/24/2010CN101679277A Novel peptide inhibitors of hepatitis c virus replication
03/24/2010CN101679264A inhibitors of focal adhesion kinase
03/24/2010CN101679261A Piperazine and piperidine mglur5 potentiators
03/24/2010CN101679258A 4 -pi peridinylurea compounds as soluble epoxide hydrolase inhibitors
03/24/2010CN101679235A Azetidine derivatives and their use as prostaglandin E2 antagonists
03/24/2010CN101678215A Sulfonyl amide derivatives for the treatment of abnormal cell growth
03/24/2010CN101676271A Tetracycline derivatives containing unsaturated heterocyclic amine
03/24/2010CN101676270A Novel imidazolidine derivative and use thereof
03/24/2010CN101676264A Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
03/24/2010CN101675928A Thiazoles and oxazoles useful as modulators of ATP-binding cassette transporters
03/23/2010US7683094 2-(2-((2R)-2-heptylaminomethyl-5-oxopyrrolidin-1-yl)ethylthio)-1,3-thiazole-4-carboxylic acid; EP2 and/or EP4 receptor agonist; immune disease; antiallergens; alopecia; dysmenorrhea; erectile dysfuncction; antiarthritic agents; liver, respiratory, vascular, urogenital disorder
03/23/2010US7683081 arthritis, allergic contact dermatitis, psoriasis, asthma, rheumatoid arthritis, or stroke; using producing coronary vasodilation without significant peripheral vasodilation
03/23/2010US7683073 Isoquinoline-1,3,4-trione compounds, the synthetic method and the use thereof
03/23/2010US7683070 insecticides for soil-borne insects, such as termites and white grubs; less costly and safer to use on crops; N-{4-[(4-{bis[4-(trifluoromethyl)phenyl]methylene}piperidyl)methyl]phenyl}ethoxycarboxamide, N-oxide
03/23/2010US7683063 inhibiting Vanilloid Receptor 1; Inflammatory bowel disease; Crohn's disease and ulcerative colitis; cyclo(hetero)alkenyl compound
03/23/2010CA2500485C Acyl derivatives of 5-(2-(4-(1,2 benzisothiazole-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2h-indol-2-one having neuroleptic activity
03/23/2010CA2495942C Novel 2-arylthiazole compounds as pparalpha and ppargamma agonists
03/23/2010CA2460177C 3-substituted-4-pyrimidone derivatives
03/23/2010CA2402467C Method for producing heterocyclic compounds
03/18/2010WO2010030592A1 Compounds for the treatment of hepatitis c
03/18/2010WO2010029458A2 A process for preparing quetiapine fumarate
03/18/2010WO2010029299A1 Pyrimidinone derivaties for use as medicaments
03/18/2010WO2010029082A1 Organic compounds
03/18/2010WO2010010288A3 Alkyl thiazole carbamate derivatives, preparation thereof, and use thereof as faah enzyme inhibitors
03/18/2010WO2010007382A8 Benzazepine derivatives and their use as hstamine h3 antagonists
03/18/2010WO2009134616A3 Novel inhibitors of hepatitis c virus replication
03/18/2010WO2009121507A3 Substituted enaminothiocarbonyl compounds
03/18/2010US20100069418 3-heteroaryl (amino or amido)-1-(biphenyl or phenylthiazolyl) carbonylpiperidine derivatives as orexin receptor inhibitors
03/18/2010US20100069417 Novel phenyl(4-phenylpyrimidin-2-yl)amine derivatives, their preparation, as medicaments, pharmaceutical compositions and in particular as ikk inhibitors
03/18/2010US20100069416 Azabicyclo [3.1.0] Hexyl Derivatives as Modulators of Dopamine D3 Receptors
03/18/2010US20100069404 TETRAHYDROCYCLOPENTA[b] INDOLE COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS
03/18/2010US20100069379 Bicyclic androgen and progesterone receptor modulator compounds and methods
03/18/2010US20100069375 Indolone-Acetamide Derivatives, Processes for Preparing Them and Their Uses
03/18/2010US20100069363 Substituted 4-amino-3,5-dicyano-2-thiopyridines and use thereof
03/18/2010US20100069358 Use of 7-azaindoles in the inhibition of c-jun n-terminal kinase
03/18/2010US20100069348 Novel compounds as cannabinoid receptor ligands
03/18/2010US20100066241 Novel organic electroluminescent compounds and organic electroluminescent device using the same
03/18/2010CA2736988A1 Compounds for the treatment of hepatitis c
03/18/2010CA2736970A1 Pyrimidinone derivatives for use as medicaments
03/18/2010CA2734819A1 Organic compounds